Susquehanna International Group’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-174,100
| Closed | -$850K | – | 12675 |
|
|
2025
Q1 | $850K | Sell |
174,100
-76,400
| -30% | -$459K | ﹤0.01% | 7664 |
|
|
2024
Q4 | $2.09M | Buy |
250,500
+248,285
| +11,209% | +$2.17M | ﹤0.01% | 5226 |
|
|
2024
Q3 | $23K | Sell |
2,215
-10,620
| -83% | -$177K | ﹤0.01% | 11595 |
|
|
2024
Q2 | $252K | Sell |
12,835
-15,905
| -55% | -$319K | ﹤0.01% | 9842 |
|
|
2024
Q1 | $736K | Sell |
28,740
-14,035
| -33% | -$360K | ﹤0.01% | 7595 |
|
|
2023
Q4 | $1.18M | Buy |
42,775
+24,015
| +128% | +$1.46M | ﹤0.01% | 6582 |
|
|
2023
Q3 | $1.14M | Buy |
18,760
+17,775
| +1,805% | +$1.25M | ﹤0.01% | 6340 |
|
|
2023
Q2 | $64.8K | Sell |
985
-3,350
| -77% | -$245K | ﹤0.01% | 11219 |
|
|
2023
Q1 | $276K | Buy |
4,335
+3,785
| +688% | +$432K | ﹤0.01% | 9904 |
|
|
2022
Q4 | $76.1K | Sell |
550
-5,335
| -91% | -$752K | ﹤0.01% | 11174 |
|
|
2022
Q3 | $745K | Buy |
5,885
+3,050
| +108% | +$345K | ﹤0.01% | 7400 |
|
|
2022
Q2 | $235K | Buy |
2,835
+1,500
| +112% | +$116K | ﹤0.01% | 10221 |
|
|
2022
Q1 | $129K | Sell |
1,335
-1,300
| -49% | -$172K | ﹤0.01% | 11711 |
|
|
2021
Q4 | $526K | Sell |
2,635
-14,812
| -85% | -$3.5M | ﹤0.01% | 9048 |
|
|
2021
Q3 | $4.32M | Buy |
17,447
+14,984
| +608% | +$4.28M | ﹤0.01% | 4224 |
|
|
2021
Q2 | $1.02M | Buy |
2,463
+834
| +51% | +$330K | ﹤0.01% | 7702 |
|
|
2021
Q1 | $636K | Sell |
1,629
-6,269
| -79% | -$3.09M | ﹤0.01% | 8914 |
|
|
2020
Q4 | $4.43M | Sell |
7,898
-1,142
| -13% | -$724K | ﹤0.01% | 3614 |
|
|
2020
Q3 | $6.32M | Sell |
9,040
-4,200
| -32% | -$3.28M | ﹤0.01% | 2764 |
|
|
2020
Q2 | $10.5M | Buy |
13,240
+8,446
| +176% | +$6.37M | ﹤0.01% | 2081 |
|
|
2020
Q1 | $2.85M | Sell |
4,794
-11,472
| -71% | -$11.2M | ﹤0.01% | 3374 |
|
|
2019
Q4 | $18.5M | Sell |
16,266
-2,362
| -13% | -$2.57M | 0.01% | 1495 |
|
|
2019
Q3 | $22.2M | Buy |
18,628
+494
| +3% | +$754K | 0.01% | 1261 |
|
|
2019
Q2 | $29.9M | Sell |
18,134
-8,500
| -32% | -$14.7M | 0.01% | 1011 |
|
|
2019
Q1 | $54.3M | Sell |
26,634
-32,825
| -55% | -$57.8M | 0.02% | 584 |
|
|
2018
Q4 | $76.4M | Buy |
59,459
+21,500
| +57% | +$33M | 0.03% | 453 |
|
|
2018
Q3 | $71.8M | Buy |
37,959
+12,344
| +48% | +$25.5M | 0.02% | 542 |
|
|
2018
Q2 | $52.1M | Buy |
25,615
+2,393
| +10% | +$5.45M | 0.02% | 670 |
|
|
2018
Q1 | $51.4M | Buy |
23,222
+487
| +2% | +$1.24M | 0.02% | 649 |
|
|
2017
Q4 | $52.5M | Sell |
22,735
-2,764
| -11% | -$5.61M | 0.02% | 672 |
|
|
2017
Q3 | $45.4M | Sell |
25,499
-6,238
| -20% | -$8.72M | 0.02% | 686 |
|
|
2017
Q2 | $43.2M | Buy |
31,737
+9,380
| +42% | +$11.3M | 0.02% | 686 |
|
|
2017
Q1 | $26.3M | Sell |
22,357
-1,289
| -5% | -$1.31M | 0.01% | 884 |
|
|
2016
Q4 | $18.9M | Buy |
23,646
+8,661
| +58% | +$6.88M | 0.01% | 1092 |
|
|
2016
Q3 | $13.2M | Buy |
14,985
+1,382
| +10% | +$1M | 0.01% | 1314 |
|
|
2016
Q2 | $7.63M | Buy |
13,603
+3,104
| +30% | +$1.76M | ﹤0.01% | 1706 |
|
|
2016
Q1 | $5.78M | Sell |
10,499
-6,948
| -40% | -$4.27M | ﹤0.01% | 2122 |
|
|
2015
Q4 | $14.5M | Buy |
17,447
+5,605
| +47% | +$5.6M | 0.01% | 1418 |
|
|
2015
Q3 | $13.1M | Sell |
11,842
-4,123
| -26% | -$7.52M | 0.01% | 1582 |
|
|
2015
Q2 | $34.8M | Sell |
15,965
-3,459
| -18% | -$7.05M | 0.01% | 900 |
|
|
2015
Q1 | $30.4M | Buy |
19,424
+9,064
| +87% | +$12M | 0.01% | 924 |
|
|
2014
Q4 | $12.3M | Buy |
10,360
+5,635
| +119% | +$3.77M | ﹤0.01% | 1798 |
|
|
2014
Q3 | $2.2M | Buy |
4,725
+3,073
| +186% | +$1.42M | ﹤0.01% | 4444 |
|
|
2014
Q2 | $825K | Buy |
+1,652
| New | +$530K | ﹤0.01% | 6455 |
|
Other funds holding BLUE
Susquehanna International Group's BLUE Position: Q2 2025 in Review
Susquehanna International Group sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 56,588 shares — an estimated $276K sold.
Susquehanna International Group first reported a position in BLUE in Q1 2014 and held it in 44 quarters. The position peaked at $53M in Q2 2018. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.
- Susquehanna International Group reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
- Susquehanna International Group sold 56,588 bluebird bio shares in Q2 2025, an estimated $276K.
- Susquehanna International Group first reported a position in bluebird bio in Q1 2014 and held it in 44 quarters.
- Susquehanna International Group's bluebird bio position peaked at $53M in Q2 2018.
- 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.